Pulsatile gonadotropin-releasing hormone in gonadotropin deficient and normal men: Suppression of follicle-stimulating hormone responses by testosterone

Timothy W. Valk, Kevin P. Corley, Robert P. Kelch, John C. Marshall

Research output: Contribution to journalArticle

27 Citations (Scopus)

Abstract

To determine the role of testosterone (T) in modulating gonadotropin secretion during sexual maturation, we studied males with isolated gonadotropin deficiency (IGD) before and during T therapy and compared the results to those in normal men. Low dose (0.025 jug/kg) pulses of gonadotropinreleasing hormone (GnRH) were given every 2 h for 5 days to four males with IGD pretreated with T (IGD-T), and responses were compared to untreated IGD men. The same protocol was performed in four normal men. All IGD males had low gonadotropins on day 0. The mean preinjection LH and FSH rose to 4.4 ± 0.4 and 15.5 ± 2.5 mlU/ml, respectively, on day 5 in the IGD patients, while plasma T levels remained low (0.7 ± 0.2 ng/ml). T therapy, which produced adult plasma T levels, suppressed the rise in gonadotropins, particularly the FSH response. Preinjection LH and FSH levels on day 5 in the IGD-T patients were 2.5 ± 0.4 and 2.9 ± 1.0 mlU/ml, respectively. In normal men the GnRH-induced LH increments were of similar magnitude to the spontaneous LH peaks present on the control day 0. Projected LH and FSH, however, rose by 65% and 45%, respectively, during days 1 and 2 of GnRH pulses, before declining on day 3 when plasma T (7.2 ± 1.4 ng/ml) and estradiol (64 ± 7 pg/ml) were significantly elevated above the control day. Standard GnRH tests (2.5 jitg/kg), performed before and after the GnRH pulses, showed augmentation of the LH and FSH responses in IGD and to a lesser degree in IGD-T patients. In contrast, normal men showed a marked reduction in gonadotropin responses. The results in GnRH-deficient patients indicate that T treatment inhibits FSH, and to a lesser extent LH secretion, by a direct action on the pituitary gland. A similar mechanism, where increasing gonadal steroid concentrations limit pituitary responses, may explain the small FSH increase to GnRH pulses in normal men. These data suggest an explanation for the patterns of LH and FSH responses to GnRH seen during spontaneous sexual maturation in males. During normal development the rising plasma T inhibits pituitary FSH secretion, so that FSH responses remain small and the marked FSH secretion seen in IGD patients does not occur.

Original languageEnglish (US)
Pages (from-to)184-191
Number of pages8
JournalJournal of Clinical Endocrinology and Metabolism
Volume53
Issue number1
DOIs
StatePublished - Jul 1981

Fingerprint

Follicle Stimulating Hormone
Gonadotropins
Gonadotropin-Releasing Hormone
Testosterone
Hormones
Plasmas
Sexual Maturation
Pituitary Gland
Estradiol
Therapeutics

ASJC Scopus subject areas

  • Endocrinology, Diabetes and Metabolism
  • Biochemistry
  • Endocrinology
  • Clinical Biochemistry
  • Biochemistry, medical

Cite this

Pulsatile gonadotropin-releasing hormone in gonadotropin deficient and normal men : Suppression of follicle-stimulating hormone responses by testosterone. / Valk, Timothy W.; Corley, Kevin P.; Kelch, Robert P.; Marshall, John C.

In: Journal of Clinical Endocrinology and Metabolism, Vol. 53, No. 1, 07.1981, p. 184-191.

Research output: Contribution to journalArticle

@article{122fec339ec64674aa078b4a2a2ade42,
title = "Pulsatile gonadotropin-releasing hormone in gonadotropin deficient and normal men: Suppression of follicle-stimulating hormone responses by testosterone",
abstract = "To determine the role of testosterone (T) in modulating gonadotropin secretion during sexual maturation, we studied males with isolated gonadotropin deficiency (IGD) before and during T therapy and compared the results to those in normal men. Low dose (0.025 jug/kg) pulses of gonadotropinreleasing hormone (GnRH) were given every 2 h for 5 days to four males with IGD pretreated with T (IGD-T), and responses were compared to untreated IGD men. The same protocol was performed in four normal men. All IGD males had low gonadotropins on day 0. The mean preinjection LH and FSH rose to 4.4 ± 0.4 and 15.5 ± 2.5 mlU/ml, respectively, on day 5 in the IGD patients, while plasma T levels remained low (0.7 ± 0.2 ng/ml). T therapy, which produced adult plasma T levels, suppressed the rise in gonadotropins, particularly the FSH response. Preinjection LH and FSH levels on day 5 in the IGD-T patients were 2.5 ± 0.4 and 2.9 ± 1.0 mlU/ml, respectively. In normal men the GnRH-induced LH increments were of similar magnitude to the spontaneous LH peaks present on the control day 0. Projected LH and FSH, however, rose by 65{\%} and 45{\%}, respectively, during days 1 and 2 of GnRH pulses, before declining on day 3 when plasma T (7.2 ± 1.4 ng/ml) and estradiol (64 ± 7 pg/ml) were significantly elevated above the control day. Standard GnRH tests (2.5 jitg/kg), performed before and after the GnRH pulses, showed augmentation of the LH and FSH responses in IGD and to a lesser degree in IGD-T patients. In contrast, normal men showed a marked reduction in gonadotropin responses. The results in GnRH-deficient patients indicate that T treatment inhibits FSH, and to a lesser extent LH secretion, by a direct action on the pituitary gland. A similar mechanism, where increasing gonadal steroid concentrations limit pituitary responses, may explain the small FSH increase to GnRH pulses in normal men. These data suggest an explanation for the patterns of LH and FSH responses to GnRH seen during spontaneous sexual maturation in males. During normal development the rising plasma T inhibits pituitary FSH secretion, so that FSH responses remain small and the marked FSH secretion seen in IGD patients does not occur.",
author = "Valk, {Timothy W.} and Corley, {Kevin P.} and Kelch, {Robert P.} and Marshall, {John C.}",
year = "1981",
month = "7",
doi = "10.1210/jcem-53-1-184",
language = "English (US)",
volume = "53",
pages = "184--191",
journal = "Journal of Clinical Endocrinology and Metabolism",
issn = "0021-972X",
publisher = "The Endocrine Society",
number = "1",

}

TY - JOUR

T1 - Pulsatile gonadotropin-releasing hormone in gonadotropin deficient and normal men

T2 - Suppression of follicle-stimulating hormone responses by testosterone

AU - Valk, Timothy W.

AU - Corley, Kevin P.

AU - Kelch, Robert P.

AU - Marshall, John C.

PY - 1981/7

Y1 - 1981/7

N2 - To determine the role of testosterone (T) in modulating gonadotropin secretion during sexual maturation, we studied males with isolated gonadotropin deficiency (IGD) before and during T therapy and compared the results to those in normal men. Low dose (0.025 jug/kg) pulses of gonadotropinreleasing hormone (GnRH) were given every 2 h for 5 days to four males with IGD pretreated with T (IGD-T), and responses were compared to untreated IGD men. The same protocol was performed in four normal men. All IGD males had low gonadotropins on day 0. The mean preinjection LH and FSH rose to 4.4 ± 0.4 and 15.5 ± 2.5 mlU/ml, respectively, on day 5 in the IGD patients, while plasma T levels remained low (0.7 ± 0.2 ng/ml). T therapy, which produced adult plasma T levels, suppressed the rise in gonadotropins, particularly the FSH response. Preinjection LH and FSH levels on day 5 in the IGD-T patients were 2.5 ± 0.4 and 2.9 ± 1.0 mlU/ml, respectively. In normal men the GnRH-induced LH increments were of similar magnitude to the spontaneous LH peaks present on the control day 0. Projected LH and FSH, however, rose by 65% and 45%, respectively, during days 1 and 2 of GnRH pulses, before declining on day 3 when plasma T (7.2 ± 1.4 ng/ml) and estradiol (64 ± 7 pg/ml) were significantly elevated above the control day. Standard GnRH tests (2.5 jitg/kg), performed before and after the GnRH pulses, showed augmentation of the LH and FSH responses in IGD and to a lesser degree in IGD-T patients. In contrast, normal men showed a marked reduction in gonadotropin responses. The results in GnRH-deficient patients indicate that T treatment inhibits FSH, and to a lesser extent LH secretion, by a direct action on the pituitary gland. A similar mechanism, where increasing gonadal steroid concentrations limit pituitary responses, may explain the small FSH increase to GnRH pulses in normal men. These data suggest an explanation for the patterns of LH and FSH responses to GnRH seen during spontaneous sexual maturation in males. During normal development the rising plasma T inhibits pituitary FSH secretion, so that FSH responses remain small and the marked FSH secretion seen in IGD patients does not occur.

AB - To determine the role of testosterone (T) in modulating gonadotropin secretion during sexual maturation, we studied males with isolated gonadotropin deficiency (IGD) before and during T therapy and compared the results to those in normal men. Low dose (0.025 jug/kg) pulses of gonadotropinreleasing hormone (GnRH) were given every 2 h for 5 days to four males with IGD pretreated with T (IGD-T), and responses were compared to untreated IGD men. The same protocol was performed in four normal men. All IGD males had low gonadotropins on day 0. The mean preinjection LH and FSH rose to 4.4 ± 0.4 and 15.5 ± 2.5 mlU/ml, respectively, on day 5 in the IGD patients, while plasma T levels remained low (0.7 ± 0.2 ng/ml). T therapy, which produced adult plasma T levels, suppressed the rise in gonadotropins, particularly the FSH response. Preinjection LH and FSH levels on day 5 in the IGD-T patients were 2.5 ± 0.4 and 2.9 ± 1.0 mlU/ml, respectively. In normal men the GnRH-induced LH increments were of similar magnitude to the spontaneous LH peaks present on the control day 0. Projected LH and FSH, however, rose by 65% and 45%, respectively, during days 1 and 2 of GnRH pulses, before declining on day 3 when plasma T (7.2 ± 1.4 ng/ml) and estradiol (64 ± 7 pg/ml) were significantly elevated above the control day. Standard GnRH tests (2.5 jitg/kg), performed before and after the GnRH pulses, showed augmentation of the LH and FSH responses in IGD and to a lesser degree in IGD-T patients. In contrast, normal men showed a marked reduction in gonadotropin responses. The results in GnRH-deficient patients indicate that T treatment inhibits FSH, and to a lesser extent LH secretion, by a direct action on the pituitary gland. A similar mechanism, where increasing gonadal steroid concentrations limit pituitary responses, may explain the small FSH increase to GnRH pulses in normal men. These data suggest an explanation for the patterns of LH and FSH responses to GnRH seen during spontaneous sexual maturation in males. During normal development the rising plasma T inhibits pituitary FSH secretion, so that FSH responses remain small and the marked FSH secretion seen in IGD patients does not occur.

UR - http://www.scopus.com/inward/record.url?scp=0019750293&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0019750293&partnerID=8YFLogxK

U2 - 10.1210/jcem-53-1-184

DO - 10.1210/jcem-53-1-184

M3 - Article

C2 - 6787065

AN - SCOPUS:0019750293

VL - 53

SP - 184

EP - 191

JO - Journal of Clinical Endocrinology and Metabolism

JF - Journal of Clinical Endocrinology and Metabolism

SN - 0021-972X

IS - 1

ER -